(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.14%) $0.800
(-0.07%) $92.11
-1.43% $ 3.45
Live Chart Being Loaded With Signals
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 173 828 |
Średni wolumen | 153 496 |
Kapitalizacja rynkowa | 213.57M |
EPS | $0 ( 2024-04-04 ) |
Następna data zysków | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.66 |
ATR14 | $0.0130 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-24 | Lewis Joel | Buy | 1 000 | Common Stock |
2023-12-31 | Czirr James C | Buy | 0 | |
2024-04-22 | Czirr James C | Sell | 21 323 | Common Stock |
2024-04-23 | Czirr James C | Sell | 3 677 | Common Stock |
2024-04-22 | Freeman Kevin D | Buy | 2 500 | Common Stock |
INSIDER POWER |
---|
24.14 |
Last 97 transactions |
Buy: 4 256 891 | Sell: 2 389 317 |
Wolumen Korelacja
Galectin Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
BRACU | 0.946 |
KIN | 0.945 |
ALGM | 0.929 |
ACVA | 0.929 |
NCAC | 0.925 |
CLBT | 0.921 |
PEGA | 0.92 |
NSIT | 0.92 |
AMYT | 0.919 |
SRRA | 0.919 |
10 Najbardziej negatywne korelacje | |
---|---|
DCRC | -0.928 |
AHPI | -0.923 |
IMV | -0.922 |
NCBS | -0.921 |
TENX | -0.92 |
LAWS | -0.919 |
CFMS | -0.919 |
TSHA | -0.918 |
VWE | -0.917 |
SGLB | -0.914 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Galectin Therapeutics Inc Korelacja - Waluta/Towar
Galectin Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-33 000.00 (0.00 %) |
EPS: | $-0.680 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-33 000.00 (0.00 %) |
EPS: | $-0.680 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-32 000.00 (0.00 %) |
EPS: | $-0.660 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.520 |
Financial Reports:
No articles found.
Galectin Therapeutics Inc
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej